Pathstone Family Office’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$10.6M Buy
181,425
+126,810
+232% +$7.42M 0.08% 164
2023
Q2
$3.69M Buy
54,615
+7,405
+16% +$501K 0.05% 207
2023
Q1
$3.33M Sell
47,210
-124,970
-73% -$8.82M 0.05% 201
2022
Q4
$9.02M Buy
172,180
+56,312
+49% +$2.95M 0.08% 186
2022
Q3
$8.46M Buy
115,868
+94,771
+449% +$6.92M 0.08% 152
2022
Q2
$1.63M Buy
21,097
+14,142
+203% +$1.09M 0.04% 240
2022
Q1
$624K Buy
6,955
+1,222
+21% +$110K 0.01% 466
2021
Q4
$357K Sell
5,733
-2,674
-32% -$167K 0.01% 659
2021
Q3
$499K Buy
8,407
+1,274
+18% +$75.6K 0.01% 513
2021
Q2
$477K Sell
7,133
-893
-11% -$59.7K 0.01% 481
2021
Q1
$508K Buy
8,026
+1,877
+31% +$119K 0.02% 337
2020
Q4
$381K Buy
6,149
+3,700
+151% +$229K 0.02% 198
2020
Q3
$147K Buy
2,449
+549
+29% +$33K 0.02% 228
2020
Q2
$112K Buy
1,900
+200
+12% +$11.8K 0.01% 213
2020
Q1
$95K Sell
1,700
-1,000
-37% -$55.9K 0.01% 227
2019
Q4
$1.73M Buy
2,700
+670
+33% +$430K 0.02% 164
2019
Q3
$104K Sell
2,030
-670
-25% -$34.3K 0.01% 192
2019
Q2
$122K Buy
2,700
+1,600
+145% +$72.3K 0.01% 242
2019
Q1
$52K Buy
1,100
+371
+51% +$17.5K 0.01% 298
2018
Q4
$38K Buy
729
+29
+4% +$1.51K 0.01% 203
2018
Q3
$43K Hold
700
0.01% 107
2018
Q2
$39K Hold
700
0.03% 84
2018
Q1
$44K Hold
700
0.02% 110
2017
Q4
$43K Hold
700
0.02% 64
2017
Q3
$45K Sell
700
-7
-1% -$450 0.04% 75
2017
Q2
$39K Sell
707
-131
-16% -$7.23K 0.02% 212
2017
Q1
$45K Buy
+838
New +$45K 0.02% 187
2016
Q4
Sell
-791
Closed -$43K 112
2016
Q3
$43K Sell
791
-76
-9% -$4.13K 0.04% 68
2016
Q2
$64K Buy
867
+700
+419% +$51.7K 0.06% 50
2016
Q1
$11K Buy
+167
New +$11K 0.02% 97
2015
Q4
Sell
-60
Closed -$4K 93
2015
Q3
$4K Buy
+60
New +$4K 0.01% 130
2013
Q4
Sell
-43
Closed -$2K 209
2013
Q3
$2K Buy
+43
New +$2K 0.01% 276